Brown J, Salas S P, Singleton A, Polak J M, Dollery C T
Physiological Laboratory, University of Cambridge, United Kingdom.
Am J Physiol. 1990 Jul;259(1 Pt 2):F26-39. doi: 10.1152/ajprenal.1990.259.1.F26.
The distribution of atrial natriuretic peptide (ANP) clearance receptors in rat kidney was investigated by in vitro autoradiography using des[Gln18,Ser19,Gly20,Leu21,Gly22]-ANP-(4- 23) (C-ANP) and 125I-Tyr0-ANP-(5-25) as relatively specific ligands of this receptor. Alpha-125I-ANP (100 pM) bound reversibly but with high affinity to glomeruli, outer medullary vasa recta bundles, and inner medulla. C-ANP (10 microM) inhibited greater than 60% of this glomerular binding but did not inhibit the binding of alpha-125I-ANP to medullary tissues. Alpha-125I-ANP also bound reversibly to the renal arteries up to the glomerulus. This arterial binding was only partly inhibited by 10 microM C-ANP. In the presence of 10 microM C-ANP, increasing concentrations of alpha-125I-ANP bound to a residue of glomerular sites with apparent dissociation constants of 0.82 +/- 0.16 to 2.73 +/- 1.20 nM at different cortical levels. 125I-Tyr0-ANP-(5-25) bound significantly to glomeruli and intrarenal arteries but not to vasa recta bundles or inner medulla. This glomerular binding also occurred with nanomolar dissociation constants. It was completely inhibited by 1 microM alpha-ANP and 10 microM C-ANP, but not by unrelated peptides such as gastrin. These results suggest that renal ANP clearance receptors are restricted in vivo to the glomeruli and renal arterial system of the rat.
利用去[Gln18,Ser19,Gly20,Leu21,Gly22]-心房钠尿肽-(4 - 23)(C - ANP)和125I - Tyr0 - 心房钠尿肽-(5 - 25)作为该受体的相对特异性配体,通过体外放射自显影法研究了大鼠肾脏中心房钠尿肽(ANP)清除受体的分布。α - 125I - ANP(100 pM)以高亲和力可逆地结合于肾小球、外髓质直小血管束和内髓质。C - ANP(10 μM)抑制了该肾小球结合的60%以上,但不抑制α - 125I - ANP与髓质组织的结合。α - 125I - ANP也以可逆方式结合至肾小球前的肾动脉。这种动脉结合仅被10 μM C - ANP部分抑制。在存在10 μM C - ANP的情况下,α - 125I - ANP浓度增加时结合至肾小球部位的一个残基,在不同皮质水平下其表观解离常数为0.82±0.16至2.73±1.20 nM。125I - Tyr0 - 心房钠尿肽-(5 - 25)显著结合于肾小球和肾内动脉,但不结合于直小血管束或内髓质。这种肾小球结合也以纳摩尔解离常数发生。它被1 μM α - ANP和10 μM C - ANP完全抑制,但不被胃泌素等无关肽抑制。这些结果表明,大鼠体内的肾ANP清除受体局限于肾小球和肾动脉系统。